نتایج جستجو برای: hcv genotype

تعداد نتایج: 109082  

Journal: :Journal of Saidu Medical College 2022

Background: Hepatitis C infection is highly prevalent in Pakistan. Six genotypes have been identified up till now. The most genotype 3 However, literature has shown variations among different regions the prevalence of genotypes.
 Objective: Purpose this study was to determine what common hepatitis Peshawar district KPK, Pakistan.
 Material & Methods: This cross-sectional conducted...

2016
Miki Taniguchi Megumi Tasaka-Fujita Mina Nakagawa Takako Watanabe Fukiko Kawai-Kitahata Satoshi Otani Fumio Goto Hiroko Nagata Shun Kaneko Sayuri Nitta Miyako Murakawa Yuki Nishimura-Sakurai Seishin Azuma Yasuhiro Itsui Kenichi Mori Shintaro Yagi Sei Kakinuma Yasuhiro Asahina Mamoru Watanabe

BACKGROUND AND AIMS The hepatitis C virus (HCV) genotype 1b is known to exhibit treatment resistance with respect to interferon (IFN) therapy. Substitution of amino acids 70 and 91 in the core region of the 1b genotype is a significant predictor of liver carcinogenesis and poor response to pegylated-IFN-α and ribavirin therapy. However, the molecular mechanism has not yet been clearly elucidate...

2014
Zhen Yang Yongxin Yu Hongzhong Zhang Guifang Shang Jialiang Gao Jian-Dong Jiang Zonggen Peng

HCV genotypes have been documented in clinical practice. The aim of this study was to determine the replication priority of different HCV genotypes in a Chinese HCV positive cohort. Serum samples from 491 apparently healthy Chinese blood donors testing positive for HCV antibodies and naive to antiviral drug therapy were tested. Genotyping analysis showed that genotypes 1b and 2a were predominan...

Journal: :Vojnosanitetski pregled 2006
Dragan Delić Zorica Nesić Milica Prostran Ivan Boricić Nada Tomanović Milisav Cutović Ljubisa Dokić Jasmina Simonović Neda Svirtlih

BACKGROUND/AIM The natural history of hepatitis C virus (HCV) infection is variable and the factors determining the course of the illness are unclear. There are geographical variations in the distribution of different HCV genotypes, and some of them are related to the specific infection routes. Regarding our country, the dominant genotype is genotype 1b. It is unclear and still remains a questi...

2017
Kessarin Thanapirom Sirinporn Suksawatamnuay Wattana Sukeepaisarnjaroen Pisit Tangkijvanich Sombat Treeprasertsuk Panarat Thaimai Rujipat Wasitthankasem Yong Poovorawan Piyawat Komolmit

BACKGROUND Patients with chronic hepatitis C (HCV) infection have high prevalence of vitamin D deficiency. Genome-wide association study data has showed that several genetic variants within vitamin D cascade affect vitamin D function. This study aimed to determine whether genetic polymorphisms of genes in the vitamin D pathway are associated with treatment responses to pegylated interferon (PEG...

Journal: :hepatitis monthly 0
alessandro federico department of clinical and experimental medicine, division of hepatogastroenterology, second university of naples, naples, italy; department of clinical and experimental medicine, division of hepatogastroenterology, second university of naples, naples, italy. tel: +39-0815666723, fax: +39-0815666714 mario masarone department of internal medicine and hepatology, internal medicine and hepatology unit, university of salerno, salerno, italy marco romano department of clinical and experimental medicine, division of hepatogastroenterology, second university of naples, naples, italy marcello dallio department of clinical and experimental medicine, division of hepatogastroenterology, second university of naples, naples, italy valerio rosato iv division of internal medicine and hepatology, second university of naples, naples, italy marcello persico department of internal medicine and hepatology, internal medicine and hepatology unit, university of salerno, salerno, italy

conclusions the rvr is the strongest factor of svr and infection with hcv genotype 2 is significantly associated with rvr. neither biochemical and/or metabolic factors seem to exert influence on rvr. objectives the main aim of this study was to assess the strength of rvr, as a predictive factor of antiviral treatment response. patients and methods using univariate and multivariate analysis, we ...

2010
Cesar A. B. Duarte Leonardo Foti Sueli M. Nakatani Irina N. Riediger Celina O. Poersch Daniela P. Pavoni Marco A. Krieger

The strategy used to treat HCV infection depends on the genotype involved. An accurate and reliable genotyping method is therefore of paramount importance. We describe here, for the first time, the use of a liquid microarray for HCV genotyping. This liquid microarray is based on the 5'UTR - the most highly conserved region of HCV - and the variable region NS5B sequence. The simultaneous genotyp...

2015
Rujipat Wasitthankasem Sompong Vongpunsawad Nipaporn Siripon Chutima Suya Phrutsada Chulothok Kasemporn Chaiear Pairaya Rujirojindakul Sawan Kanjana Apiradee Theamboonlers Pisit Tangkijvanich Yong Poovorawan

The majority of hepatitis C virus (HCV) infection results in chronic infection, which can lead to liver cirrhosis and hepatocellular carcinoma. Global burden of hepatitis C virus (HCV) is estimated at 150 million individuals, or 3% of the world's population. The distribution of the seven major genotypes of HCV varies with geographical regions. Since Asia has a high incidence of HCV, we assessed...

2012
Zhifang Jia Yanhua Ding Suyan Tian Junqi Niu Jing Jiang

BACKGROUND Many studies have been published on the association between single nucleotide polymorphisms (SNP) near the IL28B gene and response to the combined treatments of pegylated-interferon (PegIFN) and ribavirin (RBV) in chronic HCV-infected patients, but without identical conclusions. The aim of this study was to assess impact of the IL28B polymorphisms on the effect of HCV standard treatm...

Journal: :Journal of hepatology 2012
Eric J Lawitz Daniel Gruener John M Hill Thomas Marbury Lisa Moorehead Anita Mathias Guofeng Cheng John O Link Kelly A Wong Hongmei Mo John G McHutchison Diana M Brainard

BACKGROUND & AIMS GS-5885 is an inhibitor of the hepatitis C virus (HCV) NS5A protein and exhibits potent suppression of genotype 1 HCV replicons. The safety, tolerability, pharmacokinetics, antiviral activity, and resistance profile of once-daily GS-5885 doses of 1-90 mg were evaluated in patients with chronic genotype 1 HCV. METHODS Genotype 1 HCV-infected patients were randomized to 3 days...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید